Sale to Permira

Healthcare
Sale to Permira

Summary

Baird served as exclusive financial advisor to Quotient Sciences on this transaction

About

Quotient Sciences (the “Company”), a portfolio company of GHO Capital Partners (“GHO”), recently entered into a definitive agreement to recapitalise the business with Permira. The transaction is expected to complete in Q3 2019, subject to customary regulatory approvals.

Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, delivers innovative, customized solutions to pharmaceutical and biotech customers through both individual and integrated services. The Company has brought innovation to the pharmaceutical services sector through its unique Translational Pharmaceutics® platform, which is proven to accelerate development timelines, reduce development costs, and drive improvement in R&D productivity. The Company is headquartered in Nottingham, the United Kingdom and has more than 850 employees across six operating sites in the United Kingdom and the United States.

GHO is a specialist healthcare investment firm. By applying its global capabilities and perspectives, GHO unlocks high growth healthcare opportunities in Europe, and builds market leading businesses of strategic global value. GHO’s proven investment track record reflects the unrivalled depth of industry expertise and network. GHO partners with strong management teams to unlock value in a global system that demands the provision of better, faster, cheaper healthcare. GHO is based in London, the United Kingdom.

Permira is a global investment firm. Founded in 1985, the firm advises funds with a total committed capital of approximately US$38.5bn (€33bn) and makes long-term investments, including majority control investments as well as strategic minority investments, in companies with the objective of transforming their performance and driving sustainable growth. The Permira funds have made over 250 private equity investments in five key sectors: Technology, Consumer, Financial Services, Industrials, and Healthcare. Permira employs over 250 people in 14 offices across Europe, North America and Asia.
CONTACT US TO LEARN MORE
Healthcare
Sale to Permira
Date
July 2019
Company
Quotient Sciences
Transaction
M&A
Sectors
Healthcare
Target Location
Europe
Acquiror Location
Europe

Share